Calling for rapid development of a safe and effective MERS vaccine

Microbes Infect. 2014 Jul;16(7):529-31. doi: 10.1016/j.micinf.2014.05.002. Epub 2014 Jun 12.

Abstract

The geographic spread and rapid increase in the cases of Middle East respiratory syndrome (MERS) caused by a novel coronavirus (MERS-CoV) during the past two months have raised concern about its pandemic potential. Here we call for the rapid development of an effective and safe MERS vaccine to control the spread of MERS-CoV.

Keywords: Coronavirus; MERS-CoV; Receptor; Receptor-binding domain; Vaccine.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Coronavirus Infections / prevention & control*
  • Global Health
  • Humans
  • Mice
  • Middle East Respiratory Syndrome Coronavirus / immunology*
  • Pandemics / prevention & control*
  • Viral Proteins / chemistry
  • Viral Proteins / immunology
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / chemistry*
  • Viral Vaccines / immunology

Substances

  • Viral Proteins
  • Viral Vaccines